Status of Ongoing Proceedings

For information on how to obtain public transcripts of proceedings, please contact the Registrar, Sherri Wilson by phone at 613-850-1278 or by e-mail at Sherri.Wilson@pmprb-cepmb.gc.ca

Dates of Upcoming Hearings or Pre-Hearing Conferences

Case	Event	Date / Location
-	-	-

Matters before the Board

Excessive Pricing
Patented Drug Product	Indication / Use	Patentee	Issue	Date of Notice of Hearing	Status
-	-	-	-	-	-

Judicial Review of Board Decisions and Appeals

Patented Drug Product	Indication / Use	Patentee	Issue	Date of Notice of Application	Status
Differin Differin XP	Acne	Galderma Canada Inc.	Failure to file (jurisdiction)	August 11, 2020	Court File T-906-20 (RE Board Panel’s decision of May 7, 2020) Amended Notice of Application filed on 18-JAN-2023 Motion Record in response to Motion Doc. No. 34 containing the following original document(s): 40 41 Number of copies received: 1 on behalf of Respondent filed on 04-NOV-2022 Written Submissions contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 34 filed on 04-NOV-2022 Written Submissions contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 34 filed on 16-JUN-2022 Notice of Motion contained within a Motion Record on behalf of Applicant returnable at General Sitting in Toronto on 09-AUG-2022 to begin at 09:30 duration: 2h language: E for an Order granting the Applicant leave to file the Amended Notice of Application; granting an Order that the Applicant's Application Record may be filed and served within 45 days of the date of this Order, awarding costs in respect of this motion to the Applicant; and such further and other relief as this Honorable Court may deem just. filed on 16-JUN-2022 Reasons for Order and Order dated 07-JAN-2022 rendered by The Honourable Madam Justice Furlanetto Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 10 Result: granted in part Filed on 07-JAN-2022 copies sent to parties Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1522 page(s) 365 – 388 Applicant filed affidavits on September 25, 2020

Patented Drug Product

Indication / Use

Patentee

Issue

Date of Notice of Application

Status

Differin
Differin XP

Acne

Galderma Canada Inc.

Failure to file (jurisdiction)

August 11, 2020

Court File T-906-20 (RE Board Panel’s decision of May 7, 2020)

Amended Notice of Application filed on 18-JAN-2023
Motion Record in response to Motion Doc. No. 34 containing the following original document(s): 40 41 Number of copies received: 1 on behalf of Respondent filed on 04-NOV-2022
Written Submissions contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 34 filed on 04-NOV-2022
Written Submissions contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 34 filed on 16-JUN-2022
Notice of Motion contained within a Motion Record on behalf of Applicant returnable at General Sitting in Toronto on 09-AUG-2022 to begin at 09:30 duration: 2h language: E for an Order granting the Applicant leave to file the Amended Notice of Application; granting an Order that the Applicant's Application Record may be filed and served within 45 days of the date of this Order, awarding costs in respect of this motion to the Applicant; and such further and other relief as this Honorable Court may deem just. filed on 16-JUN-2022
Reasons for Order and Order dated 07-JAN-2022 rendered by The Honourable Madam Justice Furlanetto Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 10 Result: granted in part Filed on 07-JAN-2022 copies sent to parties Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1522 page(s) 365 – 388
Applicant filed affidavits on September 25, 2020

Other Court Proceedings Relevant to the PMPRB

Issue	Applicant	Respondent	Court	Status
-	-	-	-	-

Page details

Date modified:: 2023-02-23

Language selection

Search